Last Posted: May-20-2024 14:09:01
Vaccine effectiveness against emerging COVID-19 variants using digital health data
Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates
RH Holm et al, Comm Med, April 9, 2024
Concerted efforts toward genomic surveillance of viral pathogens in immunocompromised individuals.
Matheus Filgueira Bezerra et al. Lancet Microbe 2024 4
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response.
Martina Esposito et al. Commun Med (Lond) 2024 4 (1) 63
Erin E Gill et al. ArXiv 2024 5
Immune evasiveness of SARS-CoV-2 variants and vaccine selection.
Inghammar Malin, et al. The Lancet. Infectious diseases 2024 0 0.
Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
Moustsen-Helms Ida Rask, et al. The Lancet. Infectious diseases 2024 0 0.
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice.
Ann Costa Clemens Sue, et al. Vaccine 2024 0 0.
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Zaeck Luca M, et al. Nature communications 2024 0 0. (1) 4224
All Latest
About COVID-19 GPH
Site Citation:
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Special Topics
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
Mechanism | Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action |
Transmission | Characteristics and modes of covid-19 transmissions, such as human-to-human |
Diagnosis | Disease assessment through symptoms, test results, and radiological features |
Prevention | Prevention, control, response and management strategies |
Case Report | Descriptions of specific patient cases |
Forecasting | Modelling and estimating the trend of covid-19 spread |
Health Equity | Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others. |
Vaccine | Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages |
Variant | Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page |
Surveillance | Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker |
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source: